Nephrogenetic disorder are hereditary and are passed from one generation to another. These are caused by any genetic alteration in the genes affecting the kidney functions and formation of renal cyst. Some of the common genetic renal disorders include Autosomal Dominant Polycystic Kidney Disease (ADPKD), Gitelman Syndrome, Nephronophthisis, etc. The nephro genetic testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the domain. These method provide an accurate course of treatment and specific investigations.
This report contains market size and forecasts of Nephro Genetic Testing in Global, including the following market information:
Global Nephro Genetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nephro Genetic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next Generation Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nephro Genetic Testing include Centogene, MedGenome, Blueprint Genetics, Invitae Corporation and Natera, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nephro Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nephro Genetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nephro Genetic Testing Market Segment Percentages, by Type, 2021 (%)
Next Generation Sequencing
Multiplex Ligation-dependent Probe Amplification (MLPA)
Global Nephro Genetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nephro Genetic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
Global Nephro Genetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nephro Genetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nephro Genetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nephro Genetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Centogene
MedGenome
Blueprint Genetics
Invitae Corporation
Natera